Purple Biotech Ltd.

NASDAQ: PPBT · Real-Time Price · USD
2.43
0.12 (5.19%)
At close: Aug 15, 2025, 3:59 PM
2.28
-6.17%
After-hours: Aug 15, 2025, 04:48 PM EDT

Purple Biotech Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
7.4M 14.49M 15.03M 10.89M
Short-Term Investments
1.12M 923K 17.08M 36.31M
Long-Term Investments
n/a n/a n/a 187K
Other Long-Term Assets
n/a n/a n/a 160K
Receivables
275K n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
109K 171K 146K 268K
Total Current Assets
8.91M 15.79M 33.26M 48.47M
Property-Plant & Equipment
288K 470K 682K 896K
Goodwill & Intangibles
27.84M 28.04M 20.68M 20.48M
Total Long-Term Assets
28.13M 28.51M 21.37M 21.73M
Total Assets
37.04M 44.3M 54.62M 70.2M
Account Payables
1.46M 3.53M 2.13M 1.47M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
1.15M 673K 698K 611K
Total Current Liabilities
3.99M 7.18M 7.06M 4.25M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
140K 2.66M 145K 292K
Total Long-Term Liabilities
140K 2.82M 466K 842K
Total Liabilities
4.13M 10.01M 7.52M 5.09M
Total Debt
183K 351K 515K 749K
Common Stock
n/a n/a n/a n/a
Retained Earnings
-144.69M -137.45M -117.58M -95.91M
Comprehensive Income
-98K -79K 10.06M 8.76M
Shareholders Equity
32.86M 34.21M 46.91M 64.83M
Total Investments
1.12M 923K 17.08M 36.5M